Obicetrapib (AMG-899,TA-8995)
Modify Date: 2024-04-05 20:12:14
Obicetrapib (AMG-899,TA-8995) structure
|
Common Name | Obicetrapib (AMG-899,TA-8995) | ||
|---|---|---|---|---|
| CAS Number | 866399-87-3 | Molecular Weight | 722.59800 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C32H31F9N4O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Obicetrapib (AMG-899,TA-8995)Obicetrapib is a CETP inhibitor, on the elevation of high-density lipoprotein cholesterol (HDL-C) and reduction of low-density lipoprotein cholesterol (LDL-C), alone and in combination with statin therapy. |
| Name | 4-((2-((3,5-bis(trifluoromethyl)benzyl)((2R,4S)-1-(ethoxycarbonyl)-2-ethyl-6-(trifluoromethyl)-1,2,3,4-tetrahydroquinolin-4-yl)amino)pyrimidin-5-yl)oxy)butanoic acid |
|---|---|
| Synonym | More Synonyms |
| Molecular Formula | C32H31F9N4O5 |
|---|---|
| Molecular Weight | 722.59800 |
| Exact Mass | 722.21500 |
| PSA | 105.09000 |
| LogP | 8.73470 |
| 1(2H)-Quinolinecarboxylic acid, 4-[[[3,5-bis(trifluoromethyl)phenyl]methyl][5-(3-carboxypropoxy)-2-pyrimidinyl]amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-, 1-ethyl ester,(2R,4S)- |